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Objective: Suicide prediction, prevention, and intervention are urgent research areas. One barrier 
for research with high-risk populations is limited resources to manage risk in a research setting. 
We describe using the University of Washington Risk Assessment Protocol (UWRAP) to assess 
and manage suicide risk during phone-administered eligibility assessments in two clinical trials.
Method: Study 1 (N=151) recruited suicidal adults who were not engaged in mental health 
treatment and Study 2 (N=135) recruited suicidal adults who used alcohol to regulate emotions. 
Pre- and post-assessment ratings of stress, urge to harm self, urge to use drugs/alcohol, and intent 
to harm self were compared and strategies to manage increased suicide risk following screening 
interviews were implemented, as indicated.
Results: In both studies, average post-assessment ratings were significantly lower than pre-
assessment. A minority of participants reported higher ratings on one or more domains; however, 
following more thorough suicide risk assessment, risk was appropriately managed by providing 
low-level interventions (e.g., validation).
Conclusions: Suicide risk in research involving community participants can be managed by 
using appropriate risk protocols.
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Suicide is a pervasive problem in the United States and worldwide. The most recent report 
from the Centers for Disease Control and Prevention (CDC, 2018) found that the suicide rate 
rose in 49 of the 50 United States from 1999 to 2016 and the World Health Organization 
estimates that 800,000 people die by suicide worldwide annually (WHO, 2018). These 
statistics highlight the critical importance of suicide research; however, recent large-scale 
meta-analyses of decades of research point to a discouraging lack of progress toward 
understanding suicide and suicide risk (e.g., Franklin et al., 2017). Taken together, it is not 
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surprising that the CDC has identified etiology and prediction of suicide, as well as 
prevention and intervention as research priorities.
Unfortunately, relative to other lines of psychological inquiry, fewer studies focus on 
suicide-related research questions (Lakeman & Fitgerald, 2009; Mishara and Weisstub, 
2005; Wilson & Christensen, 2012). Furthermore, many clinical outcome studies exclude 
individuals at risk for suicide (Ronconi, Shiner, & Watts, 2014; Wilks, Zeive, & Lessing, 
2016; Zimmerman et al., 2017). The ubiquity of suicide coupled with the relative lack of a 
large body of suicide research ensures that our progress toward understanding and 
preventing death by suicide will be slow and minimal. Considerable barriers exist in research 
with individuals at risk for suicide. Both researchers and institutional review boards have 
expressed concerns about the logistics regarding the assessment and management of suicide 
risk in research settings (e.g., Lakeman & FitzGerald, 2009; Wilson & Christensen, 2012; 
Hom et al., 2017). Additionally, given limited availability of training in suicide risk 
assessment and management, particularly in a research context, researchers are often ill-
equipped to design and implement appropriate procedures. Given the difficulty predicting 
and preventing suicide in clinical settings (Silverman & Berman, 2014), it makes sense why 
ethical concerns about the safety of research participants would arise (Fisher et al., 2002; 
Mishara & Weisstub, 2005).
The American Psychological Association (APA) has outlined practice guidelines in 
assessing and managing suicide risk in clinical settings; these include the need to 
immediately document risk factors and clinical decision making (APA, 2003). However, 
encounters with suicidal individuals in a research context, where interactions may be brief 
and suicide risk may be uncertain, provide considerable challenges to scientists wanting to 
conduct research with suicidal subjects. As such, factors such as “clinical decision making” 
may need to be explicitly spelled out to assessors as they may not have the clinical training 
to manage suicidal crises. One such strategy is the use of protocol checklists, which can 
prompt or remind individuals to engage in recommended treatment procedures (e.g. Bellg et 
al., 2004). The University of Washington Risk Assessment Protocol (UWRAP; Linehan, 
Comtois & Ward-Ciesielski, 2012) is a wrap-around risk assessment procedure as well as a 
management protocol specifically designed for use in research assessments with suicidal or 
other high-risk participants. It involves pre- and post-assessment tracking of risk variables 
(i.e., level of stress, urge to harm self, urge to use drugs/alcohol, intent to harm self) as well 
as procedures to preemptively plan ways to manage potential increases in risk that may 
occur during participation. Finally, the UWRAP provides guidance for managing elevated 
risk during and after study participation and implementing emergency intervention, as 
needed. The UWRAP distinguishes itself from a suicide risk assessment within a treatment 
context as it outlines strategies known to reduce acute distress (e.g. identifying coping 
strategies and validating thoughts and emotions; Linehan, 1997; Stanley & Brown, 2012) 
which may not be apparent to researchers without clinical training.
One aspect included in the UWRAP is the pre-post assessment procedure, which is designed 
to evaluate potential distress and suicidal urges that may have been elicited by the 
assessment. Indeed, while previous research has consistently found that participation in 
research, even in-depth interviews, may temporarily increase emotional distress for some 
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participants, but does not increase suicide risk (e.g. Reynolds et al., 2006; Jorm, Kelly, & 
Morgan, 2007; Eynan et al., 2014; Law et al., 2015), there are instances in which individuals 
may experience elevated suicidal urges, for which suicide risk management procedures 
should be implemented.
Therefore, given the urgent need to bring more researchers into the field of suicide research, 
we describe the implementation of a suicide risk and management protocol (the UWRAP) in 
the context of two different randomized clinical trials. The aims of the current study are 1) to 
provide applied examples in which the UWRAP was used with suicidal participants, 2) to 
describe the effects of screening procedures on individuals recruited from the community for 
suicide-related research, and 3) to describe how suicide risk was managed in individuals 
who endorsed elevated urges to die. Study 1 sought to recruit adults who were currently 
experiencing suicidal ideation but not engaged in mental health treatment. Study 2 sought to 




Participants & Recruitment.—Participants for the present analyses are 151 adults 
recruited from the community of a northwestern metropolitan area via flyers, newspaper, 
online, and radio advertisements. Advertisements were designed to recruit participants who 
were currently experiencing suicidal ideation (i.e., “Are you feeling suicidal but resisting 
harming yourself?”). Data reported include those from individuals who provided consent 
and met initial eligibility criteria as described below.
Procedures.—Study procedures were reviewed and received institutional review board 
approval. As part of study eligibility screening, interested individuals who contacted the 
researchers completed a phone screening interview with a trained assessor. After providing 
verbal consent to the phone screening assessment, participants (n=298) provided basic 
demographic information related to study eligibility criteria. Individuals who were under 18 
years old, unable to come to the research office for an in-person appointment if accepted, 
unable to read or understand written English, had significant cognitive impairment, and/or 
had received face-to-face mental health treatment with a mental health provider (e.g., 
psychologist, counselor, psychiatrist) in the previous month/year2 were notified that they did 
not meet initial eligibility requirements for participation. These individuals were provided 
with referral information and the phone screening was discontinued (n=147). Individuals 
who met initial eligibility criteria (n=151) continued through the remainder of the phone 
screening by providing contact information, completing the UWRAP pre-assessment 
procedures, and answering detailed questions about current suicidal ideation and their 
mental health treatment history. Following these assessments, the UWRAP post-assessment 
1The clinical trial methods from each study have been thoroughly described elsewhere (study 1: Ward-Ciesielski, Tidik, Edwards, & 
Linehan, 2017; study 2: Wilks, Lungu, Ang, Matsumiya, Yin, & Linehan, 2018)
2For the first seven months of study recruitment, inclusion criteria required no mental health treatment during the previous year; 
however, when recruitment was progressing significantly slower than anticipated, this criterion was modified to require no mental 
health treatment in the previous month.
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procedures were completed, including a suicide risk assessment, as indicated. Participants 
were then notified about whether they met study eligibility requirements and were scheduled 
for the in-person session (if eligible) or provided with referral information (if ineligible). 
Finally, more detailed demographic information was obtained.
Study 2
Participants & Recruitment.—Participants for the second study are 135 adults recruited 
from the U.S. via online advertisements (e.g. Reddit.com, Craigslist.com). Advertisements 
were designed to recruit participants who were currently experiencing suicidal ideation and 
engaged in heavy episodic drinking (i.e. “Are you suicidal and drink alcohol to cope?”). 
Data reported include those from individuals who provided initial consent.
Procedures.—Study procedures were reviewed and received institutional review board 
approval. As part of study eligibility screening, interested individuals who contacted the 
researchers completed a phone screening interview with a trained assessor. After providing 
verbal consent to the phone screening assessment, participants (n=153) provided basic 
demographic information related to study eligibility criteria. Individuals who were under 18 
years old, did not have Internet, were unwilling to discontinue psychological treatment for 
alcohol use or emotional problems, and/or unable to read or understand written English were 
notified that they did not meet initial eligibility requirements for participation. These 
individuals were provided with referral information and the phone screening was 
discontinued (n=18). Individuals who met initial eligibility criteria (n=135) continued 
through the remainder of the phone screening by providing contact information, completing 
the UWRAP pre-assessment procedures, and answering detailed questions about current 
suicidal ideation, alcohol use, emotion regulation capabilities, and their mental health 
treatment history. Following these assessments, the UWRAP post-assessment procedures 
were completed, including a suicide risk assessment, as indicated. Participants were then 
notified about whether they met study eligibility requirements and were emailed or mailed 
an informed consent to be returned (if eligible) or provided with referral information (if 
ineligible).
Measures
Demographics Data Schedule.—Participant demographic information was obtained 
using the Demographic Data Schedule – Short Version (DDS; Linehan, 1982) which collects 
a variety of demographic information such as sex, age, ethnicity, race, marital status, 
income, educational level, and occupation. The DDS has demonstrated high concurrent 
validity to responses from hospital chart data for a sample of psychiatric inpatients (Linehan, 
1982).
The University of Washington Risk Assessment Protocol.—The UWRAP 
(Linehan et al., 2012) is a structured method to assess and manage suicide risk in the context 
of research assessments. The UWRAP has been developed for treatment outcome studies for 
use by masked assessors to manage risk without involving the study therapist. At the 
beginning of the assessment (i.e., UWRAP pre-assessment), participants are asked whether 
they have ingested medications, drugs, and/or alcohol, and whether they believe that the 
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substances would affect their performance on the assessment. In addition, participants are 
asked to rate their level of stress, urge for self-harm, suicide intent, and urge to use drugs or 
alcohol on a 1–7 point Likert scale (1 = low, 7 = high). Prior to beginning the assessment, 
participants are queried on how they can manage distress throughout the interview, which 
the interviewer documents and may implement if participant distress is high. At the end of 
the assessment (i.e., UWRAP post-assessment), participants are re-assessed on the 
aforementioned dimensions of stress level, self-harm urge, suicide intent, and drugs/alcohol 
use urge. At the post-interview assessment, a response on the question, “what is your intent 
to kill yourself?” of 4 or higher, an increase by 3 or more points (i.e. 1/7 at pre and a 4/7 at 
post), or a report that they are unsure of their ability to control suicidal urges prompts the 
assessor to implement a more thorough suicide risk assessment protocol. Regardless of 
suicide risk, assessors complete a mood improvement protocol, which includes questions 
such as, “how will you cope with any of the negative emotions that have been prompted by 
this assessment?” and “do you have any fun plans today?” For those requiring additional 
suicide risk assessment (SRA), assessors further assess risk by asking more detailed 
questions about suicide plans, methods, preparation, and other imminent risk factors and 
then provide appropriate interventions ranging from providing additional support via 
validation or distraction to using emergency services to get the participant to their nearest 
emergency department. See Figure 1 for a visual flow of the UWRAP procedures.
Statistical Analysis Strategy
To determine changes in participants’ level of stress as well as urges for self-harm, suicide, 
and drug and alcohol use pre- to post assessment, we used a paired sample t-tests with a 
95% confidence interval. We used Cohen’s d to calculate effect size for the within subject 
design and was calculated using the following formula: d =  t/ df.
Results
On average, participants identified as mostly male (53.3%), Caucasian (89.1%), and single 
(61.8%). See Table 1 for full participant demographics.
Upon starting the assessment, 42.7% of participants endorsed using drugs, alcohol, and/or 
medications immediately prior to the assessment; however, only 4.2% of those who 
endorsed medication, drugs, and/or alcohol use indicated that they believed this use would 
interfere with their performance, at which point we discontinued the interview and 
rescheduled for another time. At the beginning of the assessment, the average level of stress 
was considered moderate (M=4.69, SD=1.64), while urge to engage in self-harm (M=2.78, 
SD=1.72) and intent to kill self (M=2.13, SD=1.56) were considerably lower on average. 
The sample’s average urge to use drugs or alcohol was also considered moderately high at 
the beginning of the assessment (M=4.08, SD=2.28). On average, all subjective reports of 
stress, self-harm, suicide intent, and urges to use drugs and alcohol decreased after the 
assessment (see Table 2). Results from a set of paired samples t-test showed that, on average, 
participants’ scores decreased significantly on stress t[259] = 5.60, p < .001, 95% CI [0.35, 
0.73], albeit with a small effect size (d = .35), urge for self-harm, t[262] = 7.852 p < .001, 
95% CI [0.49, 0.83], with a medium effect (d = .48), intent to kill self t[262] = 6.00, p 
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< .001, 95% CI [0.30, 0.59], with a small effect (d = .37), and urge to use drugs and alcohol, 
t[261] = 3.91, p < .001, 95% CI [0.19, 0.57], with a small effect (d = .24).
To address the third aim, we also examined what proportion of individuals reported an 
increase in their levels of stress, self-harm and alcohol/drug use urges, with an emphasis on 
suicide intent. While the majority of individuals reported the same or lower levels of distress 
than in the beginning of the assessment, 18.4% reported increased stress, 7.0%, increased 
urges for self-harm, 5.5% increased suicide intent, and 15.7% increased urges to use drugs 
or alcohol (see Table 3 and Figures 2a–2d). At the end of the assessment, 4.2% of 
participants required further assessment and crisis management using the suicide risk 
assessment (SRA) procedures by the interviewer or supervising clinician. In the event that 
participants endorsed an elevated urge or prolonged urge for suicide (i.e., increase by 3 or 
higher than 4 out of 7), assessors were prompted to engage in various strategies from the 
SRA and would reassess risk. The SRA portion of the UWRAP includes suicide 
management strategies ranging from “validated thoughts and feelings,” to “arranged 
hospitalization.” In the event that risk was uncertain, assessors were instructed to consult 
with licensed clinical psychologists. After completing the SRA portion from the UWRAP, 
the most common management solution was to provide support and/or validate the 
participant’s feelings (which included saying things such as, “That was really long; I’m tired 
too”), talking about other topics until the participant felt more emotionally regulated, and 
focusing on coping strategies the participant can use or has used in the past in similar 
situations. When participants were reassessed, most participants denied suicidal intent or 
plan, but rather endorsed global thoughts of death and dying. No emergency services were 
contacted (i.e., involuntary hospitalization, police visits).
Discussion
The current study sought to describe the implementation of an assessment and management 
protocol with individuals for suicide-related research. In general, participants reported 
significant reductions in their levels of stress and their urges to self-harm, die by suicide, and 
use drugs or alcohol. In addition, only a small proportion of individuals reported an increase 
in their urge to self-injure or level of suicide intent. Therefore, suicide risk was managed by 
low-level interventions such as providing support and validation, which was sufficient to 
address the varying levels of risk. While the suicide management strategies were minimal, 
the management protocol allowed for more intensive intervention including involving 
friends or family members and arranging hospitalization, although it is notable that none of 
these strategies were needed.
Recently a meta-analysis was published which punctuated that asking about suicide does not 
increase suicide risk, nor does assessment in general increase suicidal urges among 
individuals at risk for suicide (Blades, Stritzke, Page, & Brown, 2018). Indeed, our results 
add to the mounting research that suggests it is possible to safely assess and manage suicide 
risk in high-risk research with community samples. While this should be enough to appease 
IRBs to approve research on individuals at risk for suicide, there is the possibility that some 
individuals may come away from a screening encounter feeling stronger urges to die than 
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before. As such, implementing a strong-tested protocol to manage varying levels of risk is 
the silver bullet for IRB concerns.
These findings have important implications for suicide researchers and institutional review 
boards. While individuals and institutions are understandably cautious about research 
involving suicidal participants (Hom et al., 2017), the expanding body of literature suggests 
that evidence-based protocols to assess and manage suicide risk can be flexibly applied 
across a variety of research contexts. In particular, the UWRAP has demonstrated utility in 
clinical research trials as well as community-based suicide research (e.g., Reynolds et al., 
2006). We hope that this assuages concerns regarding the safety of suicide research that 
employs evidence-based risk assessment and management protocols. Researchers can 
reference applications of the UWRAP relevant to their study design when providing 
rationalization for their study protocols to institutional review boards.
Limitations of these findings warrant discussion. We present the results of two separate 
studies that recruited suicidal participants from the community who underwent phone-
screening assessment. While our intention is to present applications of the UWRAP 
procedures in community-based data collection, one limitation of the current paper is that it 
is possible that conducting these assessments by phone had an impact on participants’ 
willingness to candidly disclose their current levels of stress and urges for self-harm. To our 
knowledge, there is no prior research examining differences in willingness to disclose 
suicidality in a research context via phone versus in-person; however, it is possible that 
participants may have believed they were expected to “feel better” by the end of the 
assessments or they may have had alternate motivations to report more positive ratings (e.g., 
wanting to end the call). Since this potential “pressure” to report improvement at the end of 
the interview would also likely impact in-person ratings of distress, future research is needed 
to examine the effect of different forms of research-related risk assessment formats on 
participant disclosure and on the potential role of demand characteristics on participants’ 
self-report.
Additionally, the variety of procedures researchers may be interested in employing in 
suicide-focused studies is vast. The results we present here involved eligibility screening 
interviews required before enrolling participants into randomized trials of experimental 
interventions. This introduces two additional limitations related to generalizability. First, the 
types of individuals who responded to study advertisements may not represent the entire 
population of suicidal participants who had either not engaged in mental health treatment 
(Study 1) or were drinking to cope with emotions (Study 2). Similar to our limited 
understanding of the differences between people who do and do not seek mental health 
treatment during suicidal crises, there is an important, yet unanswered, question about the 
qualitative and quantitative differences between suicidal individuals who do and do not 
participate in research when they are suicidal. More research is needed to understand the 
extent to which these two groups are related. Second, the screening interviews for both 
studies were relatively short and limited in scope. Thus, it is unclear to what extent the 
length of the interviews would affect participants’ ratings of distress and suicide-related 
urges. Although prior research using longer, more in-depth interviews has yielded similar 
results to those obtained here (e.g., Eynan et al., 2014), additional research that involves 
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longer assessment interviews would help elucidate the effect of longer interviews on these 
domains. Furthermore, a longitudinal follow-up examination would elucidate any lasting 
effects in the subgroup of participants who reported stress and/or urges.
Despite these limitations, this study provides additional evidence that it is possible to safely 
and responsibly assess and manage suicide risk within the research context. In particular, our 
study expands previous research that has primarily focused on clinical or student samples to 
demonstrate that the same protocols can effectively manage suicide risk in a wider variety of 
research contexts. Not only is it possible to conduct suicide research responsibly, 
participants generally report a decrease in their stress and suicide urges following 
completion of suicide-related assessment. To have a significant effect on the continually 
rising suicide rate in the United States, more research on the etiology and treatment of 
suicide is needed. With resources like the UWRAP available for flexible use in suicide 
research, our hope is that this will increase interest and willingness to study suicide for both 
researchers and review boards.
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Flow of University of Washington Risk Assessment Protocol in research
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Graphs showing the difference between UWRAP pre- and post-assessments.
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Table 1.
Participant demographics by study
Study1 Study 2 Total
Demographic Variable M (SD) # (%) M (SD) # (%)
Age 39.57 (14.84) 39.03 (11.37) 39.39 (13.68)
Sex (% Male) 110 (51.9) 67 (56.3) 177 (52.8)
Hispanic/Latino 11 (5.0) 9 (7.6) 20 (6.4)
Race
 Caucasian 164 (78.1) 82 (68.9) 246 (80.1)
 African American 23 (11.0) 12 (10.1) 35 (10.4)
 Asian 10 (4.7) 1 (1.0) 11 (3.6)
 Other 13 (6.2) 2 (0.1) 15 (4.9)
Highest level of education
 Less than high school 21 (9.8) 6 (6.1) 27 (8.6)
 High school 39 (18.1) 17 (17.2) 56 (17.8)
 Some college or tech school 89 (41.4) 40 (40.4) 129 (41.1)
 College graduate 48 (22.3) 29 (29.3) 77 (24.5)
 Grad school or higher 18 (8.4) 7 (7.1) 25 (8.0)
Income in last year
 Less than $5,000 64 (31.1) 22 (23.1) 86 (28.5)
 $5,000–9,999 39 (18.8) 11 (11.6) 50 (16.6)
 $10,000–14,999 37 (17.9) 11 (11.6) 48 (15.9)
 $15,000–19,999 22 (10.6) 12 (12.6) 34 (11.3)
 $20,000–24,999 10 (4.8) 13 (13.7) 23 (7.6)
 $25,000–29,999 6 (2.9) 4 (4.2) 10 (3.3)
 $30,000–49,999 23 (11.1) 14 (14.7) 37 (12.3)
 Over $50,000 6 (2.9) 8 (8.4) 14 (4.6)
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Table 2.
UWRAP pre- and post-assessment means and standard deviations













M (SD) M (SD) M (SD) M (SD) M (SD) M (SD)
Level of Stress 4.57 (1.64) 4.34 (1.67) 4.80 (1.72) 3.92 (1.93) 4.68 (1.68) 4.15 (1.80)
Urge to harm self 2.91 (1.76) 2.43 (1.58) 2.73 (1.79) 1.74 (1.24) 2.82 (1.77) 2.12 (1.48)
Intent to kill self 2.23 (1.63) 1.88 (1.31) 2.12 (1.61) 1.45 (1.03) 2.18 (1.62) 1.68 (1.21)
Urge to use drugs or alcohol 3.25 (2.25) 3.11 (2.22) 5.12 (1.90) 4.43 (2.21) 4.17 (2.28) 3.71 (2.31)
Note. Scores on each domain range from 1 (low) to 7 (high).
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Table 3.
Percent increase, decrease, and no change from pre- to post-assessment
% increase % decrease % no change
Level of Stress 18.4 40.6 41.0
Urge to harm self 7.0 41.4 51.6
Intent to kill self 5.5 64.1 30.5
Urge to use drugs or alcohol 15.7 28.2 56.1
Note. See Figures 2a–2d for corresponding visualization of change between assessments
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